Clinicopathological features of Chinese lung cancer patients with epidermal growth factor receptor mutation

被引:5
|
作者
Ning, Hui [1 ,2 ]
Liu, Ming [1 ]
Wang, Lina [3 ]
Yang, Yang [1 ]
Song, Nan [1 ]
Xu, Xiaoxiong [1 ]
Ju, Jin [4 ]
Jiang, Gening [1 ]
机构
[1] Tongji Univ, Dept Thorac Surg, Shanghai Pulm Hosp, 507 Zhengmin Rd, Shanghai 200433, Peoples R China
[2] Tianjin Haihe Hosp, Dept Thorac Surg, Tianjin 300350, Peoples R China
[3] Dalian Med Univ, Dept Endodont & Periodont, Coll Stomatol, Dalian 116044, Peoples R China
[4] Weihai Municipal Hosp, Dept Thorac Surg, 70 Heping Rd, Weihai 264200, Peoples R China
基金
中国博士后科学基金;
关键词
Lung cancer; epidermal growth factor receptor ( EGFR) gene; mutation; phenotype; genotype; EGFR MUTATIONS; TYROSINE KINASE; KRAS MUTATIONS; GEFITINIB; ADENOCARCINOMA; CHEMOTHERAPY; SENSITIVITY; INHIBITION; RESISTANCE; PATHWAYS;
D O I
10.21037/jtd.2017.03.13
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Epidermal growth factor receptor (EGFR) gene was the major causative gene of lung cancer and also the specific treatment target. It is necessary to analyze the genotype and phenotype characters of patients. Methods: We investigated 1,034 lung cancer patients in this study. The collected clinicopathological parameters included gender, age at diagnosis, smoking status, pathological TNM stage, tumor morphology and location, visceral pleural invasion as well as histological type. Results: Almost 50% participants had EGFR mutations. L858R in exon 21 was the most common type. Concomitant mutation, 19 del and L858R, were detected in 20 patients. Compared to patients with exon 19 del or L858R mutations solely, they were inclined to have small size adenocarcinomas which occurred in bilateral and invaded the visceral pleura. The tyrosine kinases inhibitors (TKIs)-resistant mutation, insertions in exon 20, was detected in 11 patients. Conclusions: The summarized clinicopathological features will help clinicians to implement the feasible treatment plan.
引用
下载
收藏
页码:796 / 801
页数:6
相关论文
共 50 条
  • [21] Epidermal growth factor receptor mutation enhances expression of vascular endothelial growth factor in lung cancer
    Hung, Ming-Szu
    Chen, I-Chuan
    Lin, Paul-Yann
    Lung, Jr-Hau
    Li, Ya-Chin
    Lin, Yu-Ching
    Yang, Cheng-Ta
    Tsai, Ying-Huang
    ONCOLOGY LETTERS, 2016, 12 (06) : 4598 - 4604
  • [22] Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients
    Murray, S
    Timotheadou, E
    Linardou, H
    Vrettou, A
    Kostopoulos, I
    Skrickova, J
    Papakostantinou, C
    Christodoulou, C
    Pectasides, D
    Samantas, E
    Papakostas, P
    Skarlos, DV
    Kosmidis, P
    Fountzilas, G
    LUNG CANCER, 2006, 52 (02) : 225 - 233
  • [23] Complex Mutation of Epidermal Growth Factor Receptor (EGFR) in Patients with Non-Small Lung Cancer
    Arai, Hiromasa
    Tajiri, Michihiko
    Morita, Junya
    Kameda, Yohei
    Shiino, Kimihisa
    Okudela, Koji
    Masuda, Munetaka
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S497 - S498
  • [24] Correlation of epidermal growth factor receptor mutation status in plasma and tissue samples of patients with lung cancer
    Son, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [25] Epidermal growth factor receptor mutation in gastric cancer
    Liu, Zhimin
    Liu, Lina
    Li, Mei
    Wang, Zhaohui
    Feng, Lu
    Zhang, Qiuping
    Cheng, Shihua
    Lu, Shen
    PATHOLOGY, 2011, 43 (03) : 234 - 238
  • [26] Clinicopathological features in correlation with epidermal growth factor receptor gene mutations in non-small cell lung cancer (NSCLC)
    Tanaka, F.
    Matsumoto, S.
    Takuwa, T.
    Kondo, N.
    Okumura, Y.
    Fukuoka, K.
    Nakano, T.
    Hasegawa, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer: comparisons with immunohistochemistry, clinicopathological features and prognosis
    P Pfeiffer
    E Nexø
    SM Bentzen
    PP Clausen
    K Andersen
    C Rose
    British Journal of Cancer, 1998, 78 : 96 - 99
  • [28] Epidermal growth factor receptor mutations in Chinese patients with non-small cell lung cancer
    Zhou, C
    Su, B
    Zhao, Y
    LUNG CANCER, 2005, 49 : S153 - S153
  • [29] Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment
    Noronha, Vanita
    Choughule, Anuradha
    Patil, Vijay M.
    Joshi, Amit
    Kumar, Rajiv
    Philip, Deepa Susan Joy
    Banavali, Shripad
    Dutt, Amit
    Prabhash, Kumar
    ONCOTARGETS AND THERAPY, 2017, 10 : 2903 - 2908
  • [30] Epidermal growth factor receptor mutation testing in lung cancer: Searching for the ideal method
    Pao, William
    Laclanyi, Marc
    CLINICAL CANCER RESEARCH, 2007, 13 (17) : 4954 - 4955